The allergist's community has recently celebrated 100 year of Allergen Immunotherapy (AIT).
Unfortunately the implemention of this treatment is still impaired by some challenges. With …

Background Although there is a considerable body of knowledge about allergen
immunotherapy (AIT), there is a lack of data on the reliability of real‐world evidence (RWE) …

Background Since 1988, numerous allergen immunotherapy guidelines (AIT‐GL s) have
been developed by national and international organizations to guide physicians in AIT. Even …

Abstract Purpose The European Academy of Allergy and Clinical Immunology (EAACI) has
produced Guidelines on Allergen Immunotherapy (AIT). We sought to gauge the …

Abstract The Future of the Allergists and Specific Immunotherapy (FASIT) workshop provides
a regular platform for global experts from academia, allergy clinics, regulatory authorities …

This article continues the comprehensive international consensus (ICON) statement on
allergen immunotherapy (AIT). The initial article also recently appeared in the Journal. The …

This document builds on the previous Joint Task Force document ''Allergen immunotherapy:
a practice parameter second update''published in the Journal of Allergy and Clinical …

Allergy today is a public health concern of pandemic proportions, affecting more than 150
million people in Europe alone. In view of epidemiological trends, the European Academy of …

In this review, we report on relevant current topics in allergen immunotherapy (AIT) which
were broadly discussed during the first Aarhus Immunotherapy Symposium (Aarhus …

Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT) is a
disease‐modifying treatment for IgE‐mediated allergic disease with effects beyond …